BNP Paribas Financial Markets’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $662M | Sell |
3,043,902
-71,309
| -2% | -$15.8M | 0.32% | 50 |
|
|
2025
Q4 | $712M | Buy |
3,115,211
+118,417
| +4% | +$27M | 0.32% | 49 |
|
|
2025
Q3 | $694M | Buy |
2,996,794
+349,655
| +13% | +$71.2M | 0.37% | 36 |
|
|
2025
Q2 | $491M | Sell |
2,647,139
-428,588
| -14% | -$79.7M | 0.28% | 60 |
|
|
2025
Q1 | $644M | Buy |
3,075,727
+1,205,059
| +64% | +$234M | 0.38% | 43 |
|
|
2024
Q4 | $332M | Sell |
1,870,668
-379,043
| -17% | -$69.7M | 0.19% | 97 |
|
|
2024
Q3 | $444M | Buy |
2,249,711
+30,382
| +1% | +$5.67M | 0.3% | 56 |
|
|
2024
Q2 | $381M | Buy |
2,219,329
+190,049
| +9% | +$31.5M | 0.31% | 63 |
|
|
2024
Q1 | $370M | Buy |
2,029,280
+521,729
| +35% | +$89.9M | 0.32% | 62 |
|
|
2023
Q4 | $234M | Sell |
1,507,551
-446,911
| -23% | -$65.2M | 0.27% | 69 |
|
|
2023
Q3 | $291M | Buy |
1,954,462
+293,774
| +18% | +$43.1M | 0.37% | 41 |
|
|
2023
Q2 | $224M | Sell |
1,660,688
-520,494
| -24% | -$76.3M | 0.28% | 60 |
|
|
2023
Q1 | $348M | Buy |
2,181,182
+1,016,849
| +87% | +$155M | 0.49% | 31 |
|
|
2022
Q4 | $188M | Buy |
1,164,333
+354,686
| +44% | +$54.4M | 0.29% | 68 |
|
|
2022
Q3 | $109M | Sell |
809,647
-187,628
| -19% | -$26.9M | 0.17% | 111 |
|
|
2022
Q2 | $153M | Sell |
997,275
-321,912
| -24% | -$49.2M | 0.24% | 87 |
|
|
2022
Q1 | $214M | Buy |
1,319,187
+261,129
| +25% | +$37.9M | 0.29% | 58 |
|
|
2021
Q4 | $143M | Sell |
1,058,058
-795,487
| -43% | -$94M | 0.2% | 99 |
|
|
2021
Q3 | $200M | Sell |
1,853,545
-1,734,138
| -48% | -$198M | 0.28% | 71 |
|
|
2021
Q2 | $404M | Buy |
3,587,683
+2,766,615
| +337% | +$312M | 0.53% | 25 |
|
|
2021
Q1 | $88.9M | Buy |
821,068
+391,763
| +91% | +$41.9M | 0.13% | 169 |
|
|
2020
Q4 | $46M | Sell |
429,305
-2,240,731
| -84% | -$215M | 0.09% | 231 |
|
|
2020
Q3 | $234M | Sell |
2,670,036
-1,274,982
| -32% | -$120M | 0.33% | 56 |
|
|
2020
Q2 | $387M | Buy |
3,945,018
+2,629,648
| +200% | +$232M | 0.68% | 20 |
|
|
2020
Q1 | $100M | Buy |
1,315,370
+662,345
| +101% | +$56.4M | 0.21% | 99 |
|
|
2019
Q4 | $57.8M | Sell |
653,025
-102,795
| -14% | -$8.53M | 0.11% | 189 |
|
|
2019
Q3 | $57.2M | Sell |
755,820
-49,372
| -6% | -$3.38M | 0.1% | 201 |
|
|
2019
Q2 | $58.6M | Buy |
805,192
+497,639
| +162% | +$39.1M | 0.12% | 189 |
|
|
2019
Q1 | $24.8M | Buy |
307,553
+60,940
| +25% | +$4.99M | 0.05% | 370 |
|
|
2018
Q4 | $22.7M | Sell |
246,613
-444,500
| -64% | -$39.1M | 0.05% | 378 |
|
|
2018
Q3 | $65.4M | Sell |
691,113
-50,547
| -7% | -$4.79M | 0.1% | 207 |
|
|
2018
Q2 | $68.7M | Buy |
741,660
+172,611
| +30% | +$16.9M | 0.11% | 171 |
|
|
2018
Q1 | $53.9M | Sell |
569,049
-55,683
| -9% | -$6.12M | 0.1% | 186 |
|
|
2017
Q4 | $60.4M | Sell |
624,732
-865,248
| -58% | -$81.5M | 0.11% | 185 |
|
|
2017
Q3 | $132M | Buy |
1,489,980
+74,830
| +5% | +$5.7M | 0.32% | 60 |
|
|
2017
Q2 | $103M | Sell |
1,415,150
-9,330
| -0.7% | -$627K | 0.31% | 68 |
|
|
2017
Q1 | $92.8M | Buy |
1,424,480
+307,960
| +28% | +$19.4M | 0.25% | 89 |
|
|
2016
Q4 | $69.9M | Buy |
1,116,520
+571,287
| +105% | +$34.9M | 0.33% | 60 |
|
|
2016
Q3 | $34.4M | Sell |
545,233
-270,614
| -33% | -$17.5M | 0.14% | 117 |
|
|
2016
Q2 | $50.5M | Sell |
815,847
-411,443
| -34% | -$25.1M | 0.23% | 66 |
|
|
2016
Q1 | $70.1M | Sell |
1,227,290
-840,878
| -41% | -$46.9M | 0.3% | 63 |
|
|
2015
Q4 | $123M | Buy |
2,068,168
+247,868
| +14% | +$14.3M | 0.3% | 65 |
|
|
2015
Q3 | $99M | Buy |
1,820,300
+1,213,074
| +200% | +$79M | 0.25% | 62 |
|
|
2015
Q2 | $40.8M | Buy |
607,226
+249,607
| +70% | +$16.3M | 0.11% | 109 |
|
|
2015
Q1 | $20.9M | Sell |
357,619
-585,557
| -62% | -$35.4M | 0.06% | 208 |
|
|
2014
Q4 | $61.7M | Buy |
943,176
+180,997
| +24% | +$11.4M | 0.22% | 80 |
|
|
2014
Q3 | $44M | Buy |
762,179
+110,469
| +17% | +$6.13M | 0.04% | 194 |
|
|
2014
Q2 | $36.8M | Sell |
651,710
-34,523
| -5% | -$1.81M | 0.03% | 187 |
|
|
2014
Q1 | $35.7M | Sell |
686,233
-254,370
| -27% | -$12.9M | 0.03% | 196 |
|
|
2013
Q4 | $49.7M | Sell |
940,603
-130,777
| -12% | -$6.43M | 0.04% | 164 |
|
|
2013
Q3 | $47.9M | Buy |
1,071,380
+843,966
| +371% | +$37.4M | 0.03% | 190 |
|
|
2013
Q2 | $9.4M | Buy |
+227,414
| New | +$9.95M | 0.01% | 356 |
|
Other funds holding ABBV
VCM
VPM
BNP Paribas Financial Markets's ABBV Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its AbbVie (ABBV) stake by 2.3% in Q1 2026, selling an estimated $15.8M and leaving 3,043,902 shares worth $662M. The position accounts for 0.32% of the portfolio, ranked #50.
BNP Paribas Financial Markets first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $712M in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- BNP Paribas Financial Markets held 3,043,902 shares of AbbVie worth $662M as of Q1 2026.
- BNP Paribas Financial Markets sold 71,309 AbbVie shares in Q1 2026, an estimated $15.8M.
- AbbVie made up 0.32% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #50 holding.
- BNP Paribas Financial Markets first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's AbbVie position peaked at $712M in Q4 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.